• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Aarti Drugs Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Alchemie Group
  • BSE Code : 2975.0
  • ISIN : INE767A01016
340.30 -13 (-3.63%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    338.20

  • Today’s High

    360.00

  • Open

    353.00

  • Perv Close

    353.10

  • 52W Low

    330.05

  • 52W High

    635.00

Key Indicators

  • P/E(TTM)

    23.68

  • Mar.Cap (₹Cr.)

    3,128.55

  • Div & Yield %

    0.29

  • Book Value(₹)

    126.18

  • Debt-Equity Ratio

    -3.63

  • AGM Date

    28-Mar-2025

  • EPS

    14.35

  • P/E Ratio

    23.68

Financials Ratios

  • Debt-Equity Ratio

    0.47

  • Mar.Cap (₹Cr.)

    3,128.55

  • RONW (%)

    13.87

  • ROCE (%)

    14.97

Score Board

  • Equity (₹ in Cr.)

    91.94

  • BV (₹)

    126.20

  • Sales( ₹ in Cr.)

    2,266.91

  • NP (in Cr.)

    141.88

  • NP Var(%)

    -7.0

  • Div%

    10.0

  • CPS (₹)

    20.60

  • EPS (₹)

    15.40

  • Traded Value (₹ in Lakhs)

    3,123.95

  • 52 Week High

    635.00

  • 52 Week Low

    330.05

  • Price BSE

    340.0

  • Price NSE

    340.00

  • Market Capital( in Cr.)

    3,123.95

  • P/C Ratio

    16.50

  • P/E Ratio

    22.00

  • Price Vs.BV

    15.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 2,266.91 2,497.97 2,251.17 1,914.89 1,634.92 1,454.25
Excise Duty 2,253.74 2,488.71 2,251.17 1,914.89 1,634.92 1,454.25
Net Sales 2,266.91 2,497.97 2,251.17 1,914.89 1,634.92 1,454.25
Other Income 4.18 2.23 4.77 6.42 1.06 2.51
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 2,271.09 2,500.20 2,255.95 1,921.31 1,635.98 1,456.77
EXPENDITURE :
Raw Materials 2,253.74 2,488.71 2,251.17 1,914.89 1,634.92 1,454.25
Power & Fuel Cost 2,253.74 2,488.71 2,251.17 1,914.89 1,634.92 1,454.25
Employee Cost 80.98 75.05 69.32 69.29 60.10 53.14
Other Manufacturing Expenses 10.56 9.33 8.23 6.78 8.94 6.28
Selling & Administrative Expenses 63.86 79.21 77.98 63.47 52.46 44.96
Miscellaneous Expenses 10.56 9.33 8.23 6.78 8.94 6.28
Less : Pre-operative Expenses Capitalised :
Total Expenditure 2,078.61 2,295.39 2,000.45 1,583.83 1,469.39 1,332.91
Operating Profit 342.19 335.44 296.93 234.17 223.14 185.55
Interest 30.16 32.53 20.07 22.61 32.20 37.56
Gross Profit 192.48 204.81 255.50 337.71 174.97 127.62
Depreciation 47.67 47.29 47.39 47.60 46.67 40.39
Profit Before Tax 192.48 204.81 255.50 337.71 174.97 127.62
Tax 49.60 53.25 65.50 84.50 42.25 33.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.00 -1.25 -5.00 -4.50 -10.25 8.45
Reported Net Profit 141.88 152.81 195.00 257.71 135.67 87.26
Extraordinary Items 192.48 204.81 255.50 337.71 174.97 127.62
Adjusted Net Profit 141.88 152.81 195.00 257.71 135.67 87.26
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 9.19 9.26 9.26 23.30 4.66 2.36
P & L Balance carried down 141.88 152.81 195.00 257.71 135.67 87.26
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 10.00 10.00 10.00 25.00 20.00 10.00
Dividend Per Share(Rs) 1.00 1.00 1.00 2.50 2.00 1.00
Earnings Per Share-Unit Curr 15.35 16.50 21.04 27.65 14.56 37.00
Book Value 9.19 9.26 9.26 23.30 4.66 2.36
Book Value(Adj)-Unit Curr 9.19 9.26 9.26 23.30 4.66 2.36

Shareholding Pattern

  • Promoter Group

    55.38%

  • Public Share Holding

    44.62%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 12,750,248 13.97 12,750,248 11
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 37,796,732 41.41 37,796,732 30
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 50,546,980 55.38 50,546,980 41
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 16 0.00 16 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2,083,464 2.28 2,083,464 79
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 70,214 0.08 70,214 1
Mutual Funds / UTI 7,100,768 7.78 7,100,768 6
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 831,423 0.91 831,423 7
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 10,085,885 11.05 10,085,885 94
2] Non Institution
Bodies Corporate 951,820 1.04 951,819 532
Clearing Members 52,745 0.06 52,745 7
Directors of their Relatives 4,953,290 5.43 4,951,090 8
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 661,712 0.73 661,712 2,164
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 654,608 0.72 654,608 4,022
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,550,825 4.99 4,518,825 66
Individuals holding nominal share capital up to Rs. 1 lakh 17,648,943 19.34 17,066,119 169,023
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,408 0.00 1,408 5
Others 1,007,797 1.10 1,007,797 5
Sub Total 30,637,135 33.57 30,020,110 175,871
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 91,270,000 100.00 90,652,975 176,006

Company Background

Aarti Drugs LtdPharmaceuticals - Indian - Bulk Drugs

  • Aarti Drugs Ltd
  • BSE Code : 2975.0
  • ISIN : INE767A01016

  • Incorporation Year

    1984

  • Registered Office

    Plot No N-198 MIDC Tarapur
    Pamtembhi Village Palghar Tal, Thane,
    Maharashtra-401506

  • Telephone

    91-22-24072249

  • FAX

    91-22-24073462/24070144

  • Chairman

    C V Gogri

  • Managing Director

    Rashesh C Gogri

  • Company Secretary

    Rushikesh Deole

  • Auditor

    Gokhale & Sathe

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Aarti Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Aarti Drugs 339.80 2,271.09 2,266.91 23.68 13.65
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92